{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:07:28Z","timestamp":1776406048513,"version":"3.51.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","award":["XSTS2025179"],"award-info":[{"award-number":["XSTS2025179"]}],"id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Program for Foreign Experts, Category H","award":["H20240797"],"award-info":[{"award-number":["H20240797"]}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["821RC678"],"award-info":[{"award-number":["821RC678"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013138","name":"Hainan Provincial Department of Health","doi-asserted-by":"publisher","award":["WSJK2025QN074"],"award-info":[{"award-number":["WSJK2025QN074"]}],"id":[{"id":"10.13039\/501100013138","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDYF2023SHFZ096"],"award-info":[{"award-number":["ZDYF2023SHFZ096"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160327&82560694"],"award-info":[{"award-number":["82160327&82560694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Platform for Academicians of Hainan Province and Hainan Academician Innovation Platform Scientific Research Project","award":["YSPTZX202514"],"award-info":[{"award-number":["YSPTZX202514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00228-026-04019-5","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:45:17Z","timestamp":1774925117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population pharmacokinetic modeling and Monte Carlo simulation\u2013based dosing optimization of trimethoprim\u2013sulfamethoxazole in critically ill patients"],"prefix":"10.1007","volume":"82","author":[{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengxing","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"6","key":"4019_CR1","doi-asserted-by":"publisher","first-page":"e13737","DOI":"10.1111\/tid.13737","volume":"23","author":"BJ Tritle","year":"2021","unstructured":"Tritle BJ, Hejazi AA, Timbrook TT et al (2021) The effectiveness and safety of low dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia: a systematic review and meta-analysis. Transpl Infect Dis Off J Transplant Soc 23(6):e13737","journal-title":"Transpl Infect disease: official J Transplantation Soc"},{"issue":"11","key":"4019_CR2","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/jac\/dkac304","volume":"77","author":"J Lasko, Maxwell","year":"2022","unstructured":"Lasko MJ, Tabor-Rennie JL, Nicolau DP et al (2022) Trimethoprim\/sulfamethoxazole pharmacodynamics against stenotrophomonas maltophilia in the in vitro chemostat model. J Antimicrob Chemother 77(11):3187\u20133193","journal-title":"J Antimicrob Chemother "},{"issue":"12","key":"4019_CR3","doi-asserted-by":"publisher","first-page":"e70235","DOI":"10.1002\/bmc.70235","volume":"39","author":"X Fu","year":"2025","unstructured":"Fu X, Fu J, Gong H et al (2025) Establishing plasma concentration methodology for trimethoprim\/sulfamethoxazole: application in therapeutic drug monitoring of critically Ill patients. Biomed Chromatogr BMC 39(12):e70235","journal-title":"Biomedical chromatography: BMC"},{"key":"4019_CR4","doi-asserted-by":"crossref","unstructured":"Chen B, Chen Y, Chen M et al (2025) Population pharmacokinetics and monte carlo-based dosing optimization of trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 69(11):e0051925","DOI":"10.1128\/aac.00519-25"},{"key":"4019_CR5","doi-asserted-by":"crossref","unstructured":"Baethke R, Golde G, Gahl G (1972) Sulphamethoxazole\/trimethoprim: pharmacokinetic studies in patients with chronic renal failure. Eur J Clin Pharmacol 4:233\u2013240","DOI":"10.1007\/BF00635802"},{"key":"4019_CR6","doi-asserted-by":"crossref","unstructured":"Singlas E, Colin JN, Rottembourg J et al (1982) Pharmacokinetics of sulfamethoxazole\u2013trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis. Eur J Clin Pharmacol 21(5):409\u2013415","DOI":"10.1007\/BF00542328"},{"issue":"9","key":"4019_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/FPC.0000000000000441","volume":"31","author":"YS Huang","year":"2021","unstructured":"Huang YS, Tseng SY, Chang TE et al (2021) Sulfamethoxazole-trimethoprim-induced liver injury and genetic polymorphisms of NAT2 and CYP2C9 in Taiwan. Pharmacogenet Genomics 31(9):200\u2013206","journal-title":"Pharmacogenetics genomics vol"},{"key":"4019_CR8","doi-asserted-by":"crossref","unstructured":"van der Ven AJ, Vree TB, van Ewijk-Beneken Kolmer EW etal (1995) Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br J Clin Pharmacol 39(6):621\u2013625","DOI":"10.1111\/j.1365-2125.1995.tb05721.x"},{"issue":"2","key":"4019_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1128\/AAC.05037-11","volume":"56","author":"H Kagaya","year":"2012","unstructured":"Kagaya H, Miura M, Niioka T et al (2012) Influence of NAT2 polymorphisms on sulfamethoxazole pharmacokinetics in renal transplant recipients. Antimicrob Agents Chemother 56(2):825\u2013829","journal-title":"Antimicrob agents Chemother"},{"issue":"1","key":"4019_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cpt.3421","volume":"117","author":"E Leegwater","year":"2025","unstructured":"Leegwater E, Baidjoe L, Wilms EB et al (2025) Population pharmacokinetics of trimethoprim\/sulfamethoxazole: dosage optimization for patients with renal insufficiency or receiving continuous renal replacement therapy. Clin Pharmacol Ther 117(1):184\u2013192","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"4019_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13737","volume":"23","author":"BJ Tritle","year":"2021","unstructured":"Tritle BJ, Hejazi AA, Timbrook TT (2021) The effectiveness and safety of low dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia: a systematic review and meta-analysis. Transpl Infect Dis 23(6):e13737","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"4019_CR12","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1016\/j.bbmt.2019.07.018","volume":"25","author":"K Gkirkas","year":"2019","unstructured":"Gkirkas K, Stamouli M, Thomopoulos T et al (2019) Low dose cotrimoxazole administered in hematopoietic stem cell transplant recipients as prophylaxis for pneumocystis jirovecii pneumonia is effective in prevention of infection due to nocardia. Biol Blood Marrow Transplant 25(9):e298\u2013e299","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"4019_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2125.1994.tb04339.x","volume":"38","author":"AJ van der Ven","year":"1994","unstructured":"van der Ven AJ, Mantel MA, Vree TB et al (1994) Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole. Br J Clin Pharmacol 38(2):147\u2013150","journal-title":"Br J Clin Pharmacol"},{"key":"4019_CR14","doi-asserted-by":"crossref","unstructured":"Schlossberg D, Samuel R (2017) Bactrim, bactrim ds, septra, septra ds (trimethoprim\/sulfamethoxazole). Antibiotics Manual","DOI":"10.1002\/9781119220787"},{"issue":"2","key":"4019_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/j.1552-4604.1974.tb02300.x","volume":"14","author":"P Kremers","year":"1974","unstructured":"Kremers P, Duvivier J, Heusghem C (1974) Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. Clinical Pharmacology\u00a014(2):112\u2013117","journal-title":"Clinical Pharmacology"},{"issue":"2","key":"4019_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/clinids\/4.2.566","volume":"4","author":"GR Siber","year":"1982","unstructured":"Siber GR, Gorham CC, Ericson JF et al (1982) Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function. Rev Infect Dis 4(2):566\u2013578","journal-title":"Rev Infect Dis"},{"issue":"3","key":"4019_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","volume":"116","author":"M Ingelman-Sundberg","year":"2007","unstructured":"Ingelman-Sundberg M, Sim CS, Gomez A et al (2007) Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116(3):496\u2013526","journal-title":"Pharmacol Ther"},{"issue":"3","key":"4019_CR18","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0022-3565(25)10564-8","volume":"274","author":"H Nakamura","year":"1995","unstructured":"Nakamura H, Uetrecht J, Cribb AE et al (1995) In vitro formation, disposition and toxicity of n-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity. J Pharmacol Exp Ther 274(3):1099\u20131104","journal-title":"J Pharmacol Exp Ther "},{"issue":"1","key":"4019_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1124\/jpet.105.086009","volume":"314","author":"S Roychowdhury","year":"2005","unstructured":"Roychowdhury S, Vyas PM, Reilly TP et al (2005) Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J Pharmacol Exp Ther 314(1):43\u201352","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"4019_CR20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","volume":"19","author":"AE Cribb","year":"1991","unstructured":"Cribb AE, Miller M, Leeder JS et al (1991) Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Drug Metab Dispos 19(5):900\u2013906","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"4019_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0090-9556(25)06552-3","volume":"23","author":"AE Cribb","year":"1995","unstructured":"Cribb AE, Spielberg SP, Griffin GP (1995) N4-hydroxylation of sulfamethoxazole by cytochrome p450 of the cytochrome p4502c subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 23(3):406\u2013414","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"4019_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1124\/mol.62.3.628","volume":"62","author":"DJ Naisbitt","year":"2002","unstructured":"Naisbitt DJ, Farrell J, Gordon SF et al (2002) Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol 62(3):628\u2013637","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4019_CR23","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.jiac.2024.10.005","volume":"31","author":"K Takeda","year":"2024","unstructured":"Takeda K, Okada A, Sera S et al (2024) Efficacy and safety of a low-dose sulfamethoxazole\/trimethoprim regimen in preventing pneumocystis pneumonia: A retrospective study using a large-scale electronic medical record database. J Infect Chemother 31(2):102537","journal-title":"J Infect Chemother"},{"issue":"6","key":"4019_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/QCO.0000000000001039","volume":"37","author":"D Mokrani","year":"2024","unstructured":"Mokrani D, Luyt EC (2024) Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice. Curr Opin Infect Dis 37(6):554\u2013564","journal-title":"Curr Opin Infect Dis"},{"key":"4019_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2110-5820-4-13","volume":"4","author":"GR Brown","year":"2014","unstructured":"Brown GR (2014) Cotrimoxazole-optimal dosing in the critically ill. Ann Intensiv Care 4:13","journal-title":"Ann Intensiv Care"},{"key":"4019_CR26","doi-asserted-by":"crossref","unstructured":"Lau WK, Young LS (1976) Trimethoprim-sulfamethoxazole treatment of pneumocystis carinii pneumonia in adults. N Engl J Med 295(13):716\u2013718","DOI":"10.1056\/NEJM197609232951308"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04019-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04019-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04019-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:37:35Z","timestamp":1776404255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04019-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4019"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04019-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}